Buspirone for Anxiety in Autistic Youth

Clinical trial NCT07439042 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07439042
Sponsor: Massachusetts General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Anxiety Autism Spectrum Disorder

Start date: 2026-08-01
Primary completion: 2029-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.